Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Perrigo Company plc (PRGO : NYSE)
 
 • Company Description   
Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The firm operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the U.S., Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with consumer-focused businesses in the U.K. and Australia. The Prescription Pharmaceuticals commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.

Number of Employees: 9,900

 
 • Price / Volume Information   
Yesterday's Closing Price: $38.14 Daily Weekly Monthly
20 Day Moving Average: 1,892,934 shares
Shares Outstanding: 134.54 (millions)
Market Capitalization: $5,131.43 (millions)
Beta: 1.02
52 Week High: $50.90
52 Week Low: $31.32
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 9.03% 22.79%
12 Week 9.13% 19.96%
Year To Date -1.95% 18.04%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
THE SHARP BUILDING HOGAN PLACE
-
DUBLIN,L2 49010
IRL
ph: 353-1709-4000
fax: 269-673-9128
investor.request@perrigo.com http://www.perrigo.com
 
 • General Corporate Information   
Officers
Murray S. Kessler - Chief Executive Officer; President and Director
Rolf A. Classon - Chairman
Raymond P. Silcock - Chief Financial Officer
Bradley A. Alford - Director
Orlando D. Ashford - Director

Peer Information
Perrigo Company plc (BJCT)
Perrigo Company plc (CADMQ)
Perrigo Company plc (APNO)
Perrigo Company plc (UPDC)
Perrigo Company plc (IMTIQ)
Perrigo Company plc (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: G97822103
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/10/22
Share - Related Items
Shares Outstanding: 134.54
Most Recent Split Date: 8.00 (2.00:1)
Beta: 1.02
Market Capitalization: $5,131.43 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 2.73%
Current Fiscal Quarter EPS Consensus Estimate: $0.40 Indicated Annual Dividend: $1.04
Current Fiscal Year EPS Consensus Estimate: $2.31 Payout Ratio: 0.55
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.32
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 02/25/2022 - $0.26
Next EPS Report Date: 08/10/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 16.55
Trailing 12 Months: 20.29
PEG Ratio: -
Price Ratios
Price/Book: 1.01
Price/Cash Flow: 8.71
Price / Sales: 1.22
EPS Growth
vs. Year Ago Period: -34.00%
vs. Previous Quarter: -45.00%
Sales Growth
vs. Year Ago Period: 6.39%
vs. Previous Quarter: -2.75%
ROE
03/31/22 - 4.88
12/31/21 - 5.19
09/30/21 - 5.88
ROA
03/31/22 - 2.38
12/31/21 - 2.53
09/30/21 - 2.87
Current Ratio
03/31/22 - 4.01
12/31/21 - 2.43
09/30/21 - 2.11
Quick Ratio
03/31/22 - 2.97
12/31/21 - 1.79
09/30/21 - 1.56
Operating Margin
03/31/22 - 6.09
12/31/21 - 6.71
09/30/21 - 7.45
Net Margin
03/31/22 - -2.07
12/31/21 - -1.12
09/30/21 - -5.86
Pre-Tax Margin
03/31/22 - 5.44
12/31/21 - 6.25
09/30/21 - 3.09
Book Value
03/31/22 - 37.94
12/31/21 - 38.51
09/30/21 - 38.76
Inventory Turnover
03/31/22 - 2.65
12/31/21 - 2.49
09/30/21 - 2.41
Debt-to-Equity
03/31/22 - 0.69
12/31/21 - 0.57
09/30/21 - 0.56
Debt-to-Capital
03/31/22 - 40.75
12/31/21 - 36.15
09/30/21 - 36.05
 

Powered by Zacks Investment Research ©